Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Feasibility Study of Multi-Platform Profiling Using Biospecimens From Patients With Resected Biliary Tract Cancer

NCT04561453 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT04561453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04561453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Feasibility Study of Multi-Platform Profiling Using Biospecimens From Patients With Resected Biliary Tract Cancer
Lead sponsor
University of Washington
Phase
Observational
Overall status
Terminated
Start date
July 8, 2020
Completion date
April 4, 2025
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer, cholangiocarcinoma, distal bile duct cancer, extrahepatic cholangiocarcinoma, gallbladder cancer, hilar cholangiocarcinoma, intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma